Zydus Cadila obtains 2 FDA approvals, 1 tentativeZydus Cadila has obtained the Food and Drug Administration’s OK for generic Tecfidera, and a tentative nod for generic Ibrance. Dr. Reddy's launches generic KuvanDr. Reddy’s generic Kuvan tablets are available in a dosage strength of 100 mg in 120-count bottles. Teva rolls out generic Truvada, Atripla Teva's generic Truvada and Atripla are combination treatments available as a single pill. Dr. Reddy's intros generic Sensipar The Sensipar brand and generic had a market value of approximately $312 million for the most recent 12 months ended July 2020, according to IQVIA. Lupin launches 3 generics Lapatinib tablets, fosaprepitant for injection and atorvastatin calcium tablets had a market value of $61 million, $136 million and $559 million, respectively. Teva offers generic Tecfidera Teva’s generic is available in dosage strengths of 120 mg and 240 mg, as well as in bottle sizes of 14 capsules and 60 capsules, respectively. AAM report: Generic savings totaled $313B in 2019 The U.S. healthcare system saved $313 billion in 2019 due to low-cost generics, according to a new report by the Association for Accessible Medicines. Dr. Reddy's debuts Tecfidera generic The Tecfidera brand and generic had a market value of roughly $3.8 billion for the most recent 12 months ended June 2020, according to IQVIA. Taro launches generic of Ferriprox FDA clears Cipla’s Tecfidera generic For the year ended July 2020, IQVIA data showed U.S. sales of roughly $3.8 billion for Tecfidera. First Previous 129 130 131 132 133 Next Last